Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Trillium Therapeutics Inc. (TRIL)

14.21   0.66 (4.87%) 10-01 09:15
Open: 13.56 Pre. Close: 13.55
High: 14.3 Low: 13.41
Volume: 1,478,458 Market Cap: 1,382M
Trillium Therapeutics Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. The company is headquartered in Mississauga, Ontario and currently employs 60 full-time employees. The firm leads program, TTI-621, which is a SIRPaFc fusion protein that consists of the CD47-binding domain of human SIRPa linked to the Fc region of a human immunoglobulin (IgG1). The company is designed to act as a soluble decoy receptor, preventing CD47 from delivering its inhibitory (''do not eat'') signal. Neutralization of the inhibitory CD47 signal enables the activation of macrophage anti-tumor effects by pro-phagocytic (''eat'') signals. A Phase one clinical trial (NCT02663518) evaluating intravenous dosing of SIRPaFc in patients with cancer is ongoing, and a second Phase one trial evaluating direct intratumoral injections is underway in solid tumors and mycosis fungoides (NCT02890368). TTI-622 is an IgG4 SIRPaFc protein, which is primarily being developed for combination therapy. An IND filing is targeted for 2H/17.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 14.32 - 14.401 14.401 - 14.474
Low: 13.206 - 13.307 13.307 - 13.4
Close: 14.057 - 14.21 14.21 - 14.35

Technical analysis

as of: 2020-09-30 4:47:15 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 19.73     One year: 23.04
Support: Support1: 11.73    Support2: 8.54
Resistance: Resistance1: 16.89    Resistance2: 19.73
Pivot: 14.40
Moving Average: MA(5): 13.72     MA(20): 13.43
MA(100): 9.04     MA(250): 5.14
MACD: MACD(12,26): 0.98     Signal(9): 1.22
Stochastic oscillator: %K(14,3): 36.19     %D(3): 47.49
RSI: RSI(14): 61.34
52-week: High: 16.89  Low: 0.24  Change(%): 4513.6
Average Vol(K): 3-Month: 209375  10-Days: 187669

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
TRIL has closed above bottom band by 43.4%. Bollinger Bands are 10.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 30 Sep 2020
Is Trillium Therapeutics Inc. (TSE:TRIL) Popular Amongst Institutions? - Simply Wall St

Wed, 30 Sep 2020
Cancer Drug Bet Pays Off for Biotech CEO With 3,600% Stock Surge - Bloomberg

Wed, 30 Sep 2020
Are Options Traders Betting on a Big Move in Trillium (TRIL) Stock? - Yahoo Finance

Tue, 29 Sep 2020
Hedge Funds Are Crazy About Trillium Therapeutics Inc. (TRIL) - Yahoo Finance

Tue, 29 Sep 2020
Trillium Therapeutics Inc (NASDAQ:TRIL) Short Interest Update - MarketBeat

Mon, 28 Sep 2020
Trillium Therapeutics Inc (NASDAQ:TRIL) Given Average Rating of "Buy" by Brokerages - MarketBeat

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 98
Shares Float (M) 70
% Held by Insiders 0.07
% Held by Institutions 32.72
Shares Short (K) 2,950
Shares Short P. Month (K) 2,510

Stock Financials

EPS -2.940
EPS Est This Year -4.130
EPS Est Next Year -2.740
Book Value (p.s.) 0.540
Profit Margin
Operating Margin -23764.49
Return on Assets (ttm) -36.3
Return on Equity (ttm) -312.3
Qtrly Rev. Growth 360.0
Gross Profit (p.s.) 0.001
Sales Per Share 0.002
EBITDA (p.s.) -0.509
Qtrly Earnings Growth
Operating Cash Flow (M) -23
Levered Free Cash Flow (M) -29

Stock Valuations

PE Ratio -4.83
PEG Ratio
Price to Book value 26.31
Price to Sales 6500.08
Price to Cash Flow -59.80

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.